ebook Munafa Stock Market Course + Intraday & FNO calls  

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

My analysis of Editas Medicine is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Editas Medicine stays below 2.3, but if it comes above 2.3, then a intra day buy could be more profitable.
If you take a sell trade below 2.3, then use 2.3 as stoploss and 2.1 as target. However if you take a buy trade in Editas Medicine, then use 2.3 as stoploss and 2.52 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

ICICI Bank credit card changes: Higher fees, insurance & movie perks to go New charges kick in from Nov 25, while select cardholders will lose complimentary travel insurance and INOX benefits from December 15 - NEWS as on 2026-11-13 business-standard.com

Cabinet extends Mudra credit guarantee scheme till 2031 with ?5,000 cr The Cabinet has extended the Credit Guarantee Fund for Micro Units till March 2031 with a ?5,000 crore corpus, aiming to facilitate ?12.6 trillion in loans under the Mudra scheme. - NEWS as on 2026-11-11 business-standard.com

Festive EMIs and credit card bills: How to prioritise repayments, cut costs Prioritise repayment of secured and high-cost loans, and consider refinancing or consolidation to cut interest costs - NEWS as on 2026-11-09 business-standard.com

NBFC credit to gold jewellery, consumer durables grows over 50 pc in Sep: RBI data In September 2026, non-banking finance companies' credit to gold jewellery and consumer durables surged significantly. Credit for gold jewellery rose by 66.1 per cent to Rs 3.74 lakh crore compared to the previous year. Consumer durables also saw a 54.4 pe - NEWS as on 2026-11-06 indiatimes.com

Bank credit growth outpaces deposits at 17.94% as festive demand picks up Bank credit expanded significantly, reaching Rs 232.54 lakh crore by mid-October 2026, showing a strong 17.94 percent growth. In contrast, bank deposits increased to Rs 284.37 lakh crore, marking a 16.60 percent rise. This growth was fueled by increased li - NEWS as on 2026-10-30 indiatimes.com

Regional Management Corp. Announces Chief Credit Risk Officer Transition, Third Quarter 2026 Results, and [CO].30 Dividend Regional Management Corp. announced that on October 28, 2026, the employment of Manish Parmar, Executive Vice President and Chief Credit Risk Officer of the Company, was terminated without cause, effective immediately. The termination of Mr. Parmar’s - NEWS as on 2026-10-29 nasdaq.com

The Future of UPI in India: MDR, Credit on UPI | Mindgate | The Economic Times | Bangalore - NEWS as on 2026-10-28 indiatimes.com

Gen Z's SIP competitor is lifestyle: Sakchi Jain on growing credit culture CA and content creator Sakchi Jain talks about Gen Z's growing challenges of balancing lifestyle spending with investing - NEWS as on 2026-10-27 business-standard.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.39
  • 12Day Average: 2.55
  • 20Day Average: 2.55
  • 50Day Average: 2.63
  • 100Day Average: 2.82
  • 150Day Average: 2.85
  • 200Day Average: 2.7

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.46, 2.55, -0.04
Indicator MACD is in negative zone

Indicator ADX (14)

6.67, 30.43, 34.78
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Nov 2026 2.17 2.01 to 2.21 1.4% 1.2 times
12 Thu Nov 2026 2.14 2.12 to 2.33 -10.08% 1.67 times
11 Wed Nov 2026 2.38 2.36 to 2.52 -5.18% 0.85 times
10 Tue Nov 2026 2.51 2.48 to 2.75 -8.73% 0.68 times
09 Mon Nov 2026 2.75 2.51 to 3.01 7% 1.6 times
06 Fri Nov 2026 2.57 2.48 to 2.63 0.78% 0.74 times
05 Thu Nov 2026 2.55 2.41 to 2.68 -6.25% 0.9 times
04 Wed Nov 2026 2.72 2.61 to 2.79 4.62% 1.02 times
03 Tue Nov 2026 2.60 2.57 to 2.71 1.17% 0.75 times
02 Mon Nov 2026 2.57 2.55 to 2.78 -3.75% 0.53 times
30 Fri Oct 2026 2.67 2.60 to 2.92 -8.87% 1.25 times
29 Thu Oct 2026 2.93 2.86 to 2.98 -0.68% 1.39 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top